Justin Gover, CEO, GW Pharmaceuticals




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Justin Gover, CEO, GW Pharmaceuticals
Released on: December 31, 2013. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Justin Gover, CEO, GW Pharmaceuticals
  • Summary
  • Transcript
  • Participants
  • Company
Justin Gover, CEO, GW Pharmaceuticals
Justin Gover, CEO, GW Pharmaceuticals
Justin Gover
GW Pharmaceuticals
GW Pharmaceuticals
GW Pharmaceuticals is a pharmaceutical firm developing a portfolio of cannabinoid medicines, of which the lead product is Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain and neuropathic pain.